Antag Therapeutics (private company)

Denmark
See something wrong or missing? Let us know
Offices:Copenhagen
Business model:B2BB2C (Retail)

Antag has developed a novel anti-obesity treatment based on a highly potent inhibitor of a hormone involved in fat accumulation.

Investors: we tracked 3 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 6.62M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Antag Therapeutics

Name Criteria
Germany Biomes
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B, B2C (Retail)
  • At least one vc investor: found 2
Sweden Elypta
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 5M - 10M USD
Hungary Turbine
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 5M - 10M USD
United Kingdom Lifebit
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 5M - 10M USD
United Kingdom Ochre Bio
52%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 5M - 10M USD
Sweden Athera
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B, B2C (Retail)
  • At least one vc investor: found 1
Belgium Antelope Dx
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Spain ARTHEx Biotech S.L.
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 5M - 10M USD
United Kingdom Theolytics
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Norway No Isolation
48%
  • Similar verticals: Health services
  • Similar business models: B2B, B2C (Retail)
  • At least one vc investor: found 3
  • Total raised in a similar range: 5M - 10M USD

News about Antag Therapeutics


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Top